On November 21, Jiangsu Hengrui Pharmaceuticals (01276) spent approximately 14.8799 million Hong Kong dollars to repurchase 250,000 shares.
Hengrui Pharmaceutical (01276) announced that on November 21, 2025, it will spend approximately HK$14.8799 million to repurchase 2...
Jiangsu Hengrui Pharmaceuticals (01276) announced that on November 21, 2025, it will repurchase 250,000 shares at a cost of approximately 14.8799 million Hong Kong dollars.
Related Articles
NANSHAN AL INTL(02610): Han Yanhong appointed as Executive Director and Chief Financial Officer
KINGSOFT (03888) spent approximately 9.9959 million Hong Kong dollars to repurchase 347,000 shares on November 21st.
ZXZN QI-HOUSE(08395) Announces Profit
It is expected that the mid-term profit will not exceed 100,000 Hong Kong dollars. The company has turned from a loss to a profit compared to the same period last year.
NANSHAN AL INTL(02610): Han Yanhong appointed as Executive Director and Chief Financial Officer
KINGSOFT (03888) spent approximately 9.9959 million Hong Kong dollars to repurchase 347,000 shares on November 21st.
ZXZN QI-HOUSE(08395) Announces Profit
It is expected that the mid-term profit will not exceed 100,000 Hong Kong dollars. The company has turned from a loss to a profit compared to the same period last year.
